The bone morphogenetic protein (BMP) signaling pathway plays a central role during vasculature development. Mutations or dysregulation of the BMP pathway members have been linked to arteriovenous malformations. In the present study, we investigated the effect of the BMP modulators bone morphogenetic protein endothelial precursor-derived regulator (BMPER) and twisted gastrulation protein homolog 1 (TWSG1) on arteriovenous specification during zebrafish development and analyzed downstream Notch signaling pathway in human endothelial cells. Silencing of bmper and twsg1b in zebrafish embryos by morpholinos resulted in a pronounced enhancement of venous ephrinB4a marker expression and concomitant dysregulated arterial ephrinb2a marker expression detected by in situ hybridization. As arteriovenous specification was disturbed, we assessed the impact of BMPER and TWSG1 protein stimulation on the Notch signaling pathway on endothelial cells from different origin. Quantitative real-time PCR (qRT-PCR) and western blot analysis showed increased expression of Notch target gene hairy and enhancer of split, HEY1/2 and EPHRINB2. Consistently, silencing of BMPER in endothelial cells by siRNAs decreased Notch signaling and downstream effectors. BMP receptor antagonist DMH1 abolished BMPER and BMP4 induced Notch signaling pathway activation. In conclusion, we found that in endothelial cells, BMPER and TWSG1 are necessary for regular Notch signaling activity and in zebrafish embryos BMPER and TWSG1 preserve arteriovenous specification to prevent malformations.
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Introduction
The vertebrate blood vasculature is a closed circulatory system continually recirculating blood to and from arteries, veins, and interconnecting capillaries. In the developing embryo, this transportation system is required to supply oxygen and nutrients between organs and tissues, as well as to remove waste products. Thus, the formation of the vascular system is one of the earliest and most important events during organogenesis [1, 2] . Blood vessel formation comprises several steps during embryonic development beginning with vasculogenesis, which is the differentiation from mesodermal precursor cells, followed by angiogenesis that is the expansion from a consisting vascular plexus to generate a complex, intensively branched vasculature. To generate a hierarchical vascular tree, endothelial cell function has to be fine-tuned by a variety of growth factors and signaling cascades to enable several cellular mechanisms including migration, proliferation, differentiation, and maturation [2, 3] .
Specification of arteries and veins takes place in the early embryo during remodeling processes of the primary capillary plexus. In the past, the differentiation into arteries and veins was assumed to be induced by hemodynamic forces, but studies in zebrafish and mouse model systems have uncovered genetically predetermined events before the onset of blood flow [1, 4] . Complementary arterial marker EPHRINB2 (EFNB2) and venous marker EPHRINB4 (EPHB4) expressions are necessary for bidirectional repulsion and segregation of the blood vessel system. This interaction is essential to establish arterial-venous boundaries and proper vascular development [5] . In zebrafish, arterial fate determination consists of sequential activation of sonic hedgehog, VEGF, and Notch signaling pathway activation [6] . Upon ligand binding, the Notch receptor is proteolytically cleaved and NOTCH cleaved intracellular domain (NICD) is released from the plasma membrane to translocate into the nucleus to mediate Notch target gene expression. Notch target genes are members of the hairy and enhancer of split (HES) family of basic helix-loop-helix (bHLH)-type transcriptional repressors (HEY1 and HEY2) [7, 8] . Loss of any component of the Notch pathway in zebrafish and mice results in arteriovenous malformations underlining the importance of Notch signaling during arterial specification [9] . On the contrary, for venous specification, expression of Coup-TFII is indispensable because it inhibits Notch signaling and induces expression of venous markers (EPHB4 and NRP2) and, thus, venous specification [5] . For example, inhibition of the Notch target gene gridlock (grl) in zebrafish led to an increase in the venous marker ephB4a at the expense of decreased arterial efnb2a expression [10] .
Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-b (TGF-b) superfamily, and have been extensively studied during embryonic development, where they control axis formation and organogenesis [11] . BMPs are extracellular proteins that signal through cell surface complexes of heterodimeric transmembrane serine/threonine kinase receptors. Upon intracellular activation of the receptor, SMAD1/5 transcription factors become phosphorylated and therefore obtain the ability to translocate to the nucleus where they modulate target gene expression such as DNA-binding protein inhibitor 1 (ID1) [12, 13] . In line with the key role for BMPs during vascular development, loss of function models of BMP ligands, the BMP receptors, or SMAD1/5 show early embryonic lethality due to disturbed mesoderm development and, thus, reduced vasculature [14, 15] . During zebrafish vasculature development, BMP signaling was shown to be dispensable for intersomitic vessel (ISV) formation. However, Bmp2b signaling is necessary for venous-specific sprouting angiogenesis to generate the caudal vein plexus (CVP) [16] .
Bone morphogenetic protein signaling is highly regulated at the extracellular space by BMP modulators such as chordin, twisted gastrulation protein homolog 1 (TWSG1), and BMP endothelial cell precursorderived regulator (BMPER) [17] [18] [19] . BMPER, the vertebrate homolog of Drosophila crossveinless 2, is a secreted glycoprotein that contains five cysteine-rich domains followed by a von Willebrand D domain and a trypsin inhibitor domain and was originally identified in a screen for differentially expressed proteins in embryonic endothelial precursor cells [17] . During the last few years, BMPER has emerged to be in the focus of interest in vascular biology [20] [21] [22] [23] [24] [25] [26] . Regarding angiogenesis, we and others have previously shown that BMPER may enhance BMP signaling and the angiogenic response of endothelial cells in a concentration-dependent manner [23, 26, 27] . Along the same line, BMPER was recently shown to be indispensable for normal coronary artery plexus formation during mouse embryonic development [25] . Interestingly, studies in mice showed a genetic interaction between Bmper and Twsg1 during skeletal and nephron development, suggesting that they cooperate in fine-tuning BMP signaling [28] [29] [30] . Moreover, we have shown previously that extracellular BMP modulators, Bmper and Twsg1b, are required for the regular development of the zebrafish vasculature [22, 31] . Silencing of bmper expression by morpholinos (MO) resulted in several defects in ISV growth and disturbed formation of the CVP, whereas silencing of twsg1b caused a large ventral vascular malformation in the CVP with aberrant or decreased circulation resulting in blood accumulation [22, 32] . These findings led us to hypothesize that not only angiogenesis is disturbed after silencing of bmper and twsg1b in the zebrafish embryo, but also arteriovenous differentiation.
In this study, we aimed to investigate the BMP modulators, BMPER and TWSG1, for their ability to influence endothelial cell specification in AV differentiation.
Results
Bmper and Twsg1b morphant zebrafish embryos display dysregulated expression of the arterial marker efnb2a and venous marker ephb4a
Previously, we have shown that the extracellular BMP modulators, Bmper and Twsg1b, are both required for the regular development of the zebrafish vasculature [22, 31] . In the zebrafish embryo, silencing of bmper expression by MO resulted in several defects in ISV growth and disturbed formation of the CVP, whereas silencing of twsg1b caused a large ventral vascular ectasia in the CVP with local stasis and accumulation of blood cells [22, 32] . These findings led us to hypothesize that not only angiogenesis is disturbed after silencing of bmper and twsg1b in the zebrafish embryo, but also arteriovenous differentiation. Therefore, expression of the arterial marker gene efnb2a and the venous marker gene ephb4a were investigated in 48 hpf tg (fli1:eGFP) zebrafish embryos after injection with MOs against bmper and twsg1b. During normal blood vessel development, whole-mount in situ hybridization of zebrafish embryos at 48 hpf displayed efnb2a expression in the caudal aorta (CA) and ISVs (Fig. 1A) . As internal control for misexpression of arteriovenous markers, we silenced grl, which has been previously described to decrease efnb2a expression (Fig. 1E) and [10] . In contrast, silencing of bmper (Fig. 1B) , twsg1b (Fig. 1C) , or the combination of both (Fig. 1D ) resulted in increased efnb2a expression that is not restricted to the CA anymore and shows additional expression in the caudal vein (CV). Quantification of MO-injected embryos based on their efnb2a expression levels in the CA/CV after in situ hybridization showed increased efnb2a expression (Fig. 1F) . However, quantitative real-time PCR (qRT-PCR) of whole embryos to assess relative efnb2a mRNA expression levels did not show a significant difference in efnb2a expression (Fig. 1G) . As described earlier, blood vessel morphology is disturbed in bmper and twsg1b MO-injected embryos at 48 hpf resulting in a ventral vascular ectasia in the CVP. Compared to standard MO-injected embryos blood flow in bmperand twsg1b-silenced embryos is impaired as well as shunts occur 48 hpf (Movie S1-S4). Of interest, endothelial cells of the malformation in the CVP additionally displayed increased efnb2a expression (Fig. 1C,D) . The expression of the venous marker ephb4a in 48 hpf zebrafish embryos is restricted to the CV in control embryos ( Fig. 2A) . In grl morphants, which display a hypomorphic arterial phenotype, ephb4a expression is enhanced and expanded into the region of the CA (Fig. 2E ) as previously reported [10] . Similarly, bmper-silenced embryos also showed significantly increased and expanded ephb4a expression in the CV (Fig. 2B,F) . In comparison to bmper-silenced embryos, ephb4a expression was more pronounced in most twsg1b-silenced embryos, and the expression was expanded around the CV. Moreover, the ventral vascular ectasia in the CVP showed a strong ephb4a staining (Fig. 2C,F) . In comparison, zbmper/twsg1b MO co-injected embryos displayed an intermediate ephb4a expression phenotype between bmper and twsg1b morphants (Fig. 2D,F) . Quantification of MO-injected embryos by qRT-PCR of whole embryos showed a significant increased ephb4a expression (Fig. 1G) . Taken together, silencing of bmper and twsg1b during development of the zebrafish vasculature results in dysregulated arteriovenous differentiation.
Stimulation of endothelial cells from arterial, venous, and microvascular origin with recombinant BMPER and TWSG1 protein increases Notch signaling As misexpression of the ephrins and eph receptors suggests that aberrant Notch signaling is involved in misidentifying arteriovenous specification of endothelial cells during zebrafish embryonic development, we next assessed the effect of BMPER and TWSG1 on the Notch signaling pathway in endothelial cells. Human coronary artery endothelial cells (HCAECs), human umbilical vein endothelial cell (HUVECs), and human lung microvascular ECs (HMECs) representing the three major types of blood vessels, namely arteries, veins, and capillaries, were stimulated with recombinant BMPER or TWSG1 protein for 16 h and compared to the control medium. The intracellular cleaved NOTCH1 domain (NICD) was used as a marker for active Notch signaling. Upon ligand binding to the NOTCH1 receptor, the NICD is cleaved and released. It then enters the nucleus to regulate gene transcription [7] . Western blot analysis showed that NICD was increased after BMPER or TWSG1 stimulation in HCAECs, HUVECs, and HMECs ( Fig. 3A-C) . Along the same line, downstream Notch signaling effector HES1 was also significantly increased in all main types of endothelial cells after stimulation with BMPER ( Fig. 3D-F) . However, after stimulation with TWSG1, we only detected a robust HES1 expression in HCAECs (Fig. 3D ) in contrast to a slightly increased expression in HUVECs (Fig. 3E ). To further analyze the effect of BMPER and TWSG1 on the Notch signaling pathway, mRNA expression of Notch target genes was investigated in HUVECs ( Fig. 3G -L). Consistent with the protein expression data, HES1 expression is increased after stimulation with BMPER and TWSG1 (Fig. 3G ). In addition, mRNA expression of the Notch targets HEY1, HEY2, and vascular endothelial growth factor receptor 1 (VEGFR1) is upregulated after stimulation with BMPER, but not with TWSG1 ( Fig. 3H-J) . Compatible with Notch signaling inducing arterial identity, we found that EFNB2 expression is also increased (Fig. 3K ) and, conversely, the expression of the venous marker EPHB4 shows a trend to decrease (Fig. 3L ). However, after stimulation of HUVECs with TWSG1, we could not detect any significant differences in the expression of Notch signaling target genes, with the exception for HES1 (Fig. 3G) . Collectively, stimulation of endothelial cells with recombinant BMPER protein significantly increases the Notch signaling pathway activity and along this way upregulates the arterial marker EFNB2.
Silencing of BMPER in endothelial cells decreases Notch signaling and its downstream effectors
As BMPER-stimulated HUVECs showed consistent upregulation of the Notch signaling pathway, we hypothesized that silencing of BMPER by small interfering RNAs (siRNAs) leads to decreased NICD and downregulation of Notch signaling target genes. Knockdown efficacy for the two BMPER-specific siRNA (B1 and B2) compared with scrambled siRNA was quantified 48 h post-transfection of HCAECs, HUVECs, and HMECs on mRNA and protein levels ( blot analysis showed reduced NICD and HES1 protein levels. Accordingly, we detected reduced expression of the Notch downstream effectors HEY1, HEY2, and VEGFR1 on mRNA level in HUVECs (data not shown). To correlate our findings from the zebrafish model with our results from human endothelial cells, we silenced BMPER or TWSG1 in HCAECs, HUVECs, and HMECs and investigated EFNB2 and EPHB4 expression (Fig. 4D-O) . Of interest, silencing of BMPER or TWSG1 caused increased EPHB4 expression in all endothelial cells (Fig. 4G ,K,O) confirming our zebrafish findings. In contrast, EFNB2 expression in HUVECs is decreased after silencing of BMPER or TWSG1 (Fig. 4J) , whereas on the contrary, EFNB2 expression shows a trend toward enhanced expression in HCAECs and lung HMECs after silencing of BMPER and TWSG1 (Fig. 4F,N) . Together, these data show that lack of BMPER in endothelial cells of different origin reduces Notch signaling pathway activity as well as silencing of BMPER or TWSG1 enhanced expression of the venous marker EPHB4.
Inhibition of BMP signaling by DMH1 abolishes BMPER and BMP4 induced Notch signaling pathway activation
As BMPER is described to exert pro-or anti-BMP functions [33, 34] , we assumed that activation of the Notch pathway by BMPER is dependent on BMP signaling. Western blot analysis revealed that incubation of endothelial cells with BMPER, BMP4, or the combination of both increased NICD and HES1 protein levels, demonstrating that BMPER under the chosen conditions exerts pro-BMP function and that activation of the BMP signaling pathway induces Notch signaling (Fig. 5A,B) . To assess BMP signaling pathway activation, the BMP target gene ID1 was analyzed on protein and mRNA level displaying increased expression after stimulation with BMPER, BMP4, or the combination of both (Fig. 5C,G) . As expected, the inhibition of BMP signaling by dorsomorphin homolog 1 (DMH1), a selective inhibitor of the activin receptor-like kinase (ALK) 2 receptor, decreased ID1 expression. Accordingly, simultaneous stimulation of BMPER and BMP4 together with DMH1 prevented augmentation of NICD and HES1 on the protein level (Fig. 5A,B) . Consistent with the protein expression data, mRNA expression of HEY1, HEY2, and HES1 is increased after stimulation with BMPER, BMP4, or the combination of both. Additionally, co-incubation with DMH1 inhibited upregulation of Notch signaling target genes (Fig. 5D-F) . Taken together, our data suggest that activation of the BMP signaling pathway per se enhances Notch signaling, which is emphasized by the finding that co-application of BMP receptor inhibitor DMH1 prevents Notch pathway activation.
Inhibition of BMP signaling by DMH1 in zebrafish embryos leads to dysregulated efnb2a and ephb4a expression
As the BMP inhibitor DMH1 suppressed BMPERinduced Notch pathway activation in endothelial cells and BMPER is described to exert pro-or anti-BMP functions, we asked which effect DMH1 has on arteriovenous differentiation during zebrafish development. Therefore, embryos were dechorionized, incubated with DMH1 beginning at 12 hpf and fixated at 48 hpf, before whole-mount in situ hybridization for efnb2a and ephb4a was performed. Interestingly, DMH1-treated embryos displayed a ventral vascular ectasia in the CVP with increased efnb2a expression in the area of the CV (Fig. 6A,B) . Again, in situ hybridization for ephb4a displayed a strong increase in the CVP for DMH1-treated embryos (Fig. 6C,D) such as observed in bmper and twsg1b MO-injected zebrafish embryos. In summary, treatment of zebrafish embryos with the BMP inhibitor DMH1 leads to enhanced expression of the venous marker ephb4a.
Discussion
Over the past decade, the BMP signaling pathway has come into focus of vascular biology research, especially with regard to embryonic vasculature development and vascular diseases [4, 13, 14] . In particular, how BMP pathway family members impact endothelial cell function and differentiation during the process of blood vessel formation in mouse or zebrafish model organisms is of major interest. For example, arteriovenous malformations which are associated with dysregulated BMP signaling caused by mutations in ENDOGLIN, ALK1, BMP9, or SMAD4 have also been found in the human syndrome hereditary hemorrhagic telangiectasia (HHT) [13, 15, [35] [36] [37] [38] . Apart from the BMP pathway, anomalies in the Notch signaling pathway are also well known to be involved in arteriovenous malformations [39, 40] . Zebrafish embryos deficient for Notch activity display altered endothelial cell specification and decreased expression of efnb2a and increased ephb4a expression [1, 41] . As we have previously demonstrated that the extracellular BMP modulators, Bmper and Twsg1b, are required for the regular development of the zebrafish vasculature [22, 23, 31] , our hypothesis for this project was that silencing of bmper and twsg1b in zebrafish embryos affects endothelial cell specification and arteriovenous differentiation. Indeed, our results show that silencing of bmper and twsg1b in zebrafish embryos caused dysregulated expression of the arterial marker efnb2a and venous marker ephb4a. Additionally, an aberrant circulation and venous malformation in the CVP was detected in some embryos (Figs 1 and 2 and Movie S1-S4). In contrast to the clear phenotype after grl MO injection, which depicts a loss of arterial marker expression and gain of venous marker expansion, we detected increased arterial as well as venous marker expression after bmper and twsg1b MO injection. However, the increase in ephb4a expression was much more pronounced compared to efnb2a expression, suggesting a partial compensatory upregulation of efnb2a to balance blood vessel differentiation. Along this line, a similar observation was reported by Rost and Sumanas previously. They found that silencing of Stabilin-2 in zebrafish embryos by MOs not only resulted in expanded expression of arterial markers, but also to a more robust expression and expansion for multiple venous markers [42] . Taken together, our data suggest that unbalancing the BMP signaling pathway by inhibition of bmper and twsg1b lead to increased venous marker expression that predominates, and relating thereto, indicate a dysregulation of the Notch signaling pathway, which is centrally involved in arteriovenous specification.
Interestingly, several studies have recently investigated the interaction of the BMP pathway together with the Notch signaling pathway in blood vessel formation, and collectively suggest that maintaining the balance in Notch and BMP signaling is essential for regular vasculature development [15, 36, 43, 44] . Given that silencing of bmper and twsg1b tipped the balance of arteriovenous differentiation to the expansion of ephb4a venous marker, and together with the wellknown fact that Notch signaling is indispensable for arterial specification, activation of the Notch signaling pathway was analyzed in endothelial cells of different origin upon BMPER and TWSG1 stimulation. As expected, NICD along with its target genes HES, HEY1 and 2 were increased after stimulation with BMPER and TWSG1 (Fig. 3) . Interestingly, Notch signaling pathway activation was independent from the origin of the vascular bed (arterial, venous, or capillary), which may be due to endothelial cell plasticity and the in vitro cell culture conditions [45] . Moreover, even in vivo, there is evidence for plasticity of the vascular wall in response to changes of the microenvironment as for example after coronary artery bypass grafting where veins are grafted into the arterial circulation and acquire artery-like properties [46] .
Previous studies have shown that activation of the BMP pathway increased NICD and along this line, HEY1, HEY2, HES, and EFNB2 expression. Part of this is mediated by direct binding of the intracellular BMP signaling molecules SMAD1/5 to the HEY1 promoter [47] [48] [49] [50] . In endothelial cells, BMP and Notch pathways have been shown to have synergistic effects in increasing HEY1 and HES1 expression, but at the same time also antagonistic effects with regard to the regulation of certain cell function [51] . For example, BMP6 stimulation in endothelial cells induced the BMP target gene ID1, which enhanced cell migration. At the same time, upregulation of HEY1 expression inhibited cell migration and ID1 expression. In summary, intracellular signal integration of the two pathways resulted in reduced migration and robust Notch signaling pathway activation [51] . Our findings add that silencing of BMPER in endothelial cells decreases Notch signaling as well as silencing of BMPER and TWSG1 promotes expression of the venous differentiation marker EPHB4/ephnb4a at the expense of arterial blood vessel differentiation marker EFNB2/efnb2a in endothelial cells and zebrafish embryos (Figs 1, 2 , and 4). Furthermore, we found that BMPER modulates the Notch signaling pathway in a BMPdependent manner. Indeed, stimulation with BMP4 augmented the effect of BMPER on the Notch signaling pathway, whereas inhibition of the ALK2 receptor with DMH1 prevented Notch pathway activation by BMPER (Fig. 5 ). In accordance with these findings, Moya et al. have previously shown in an in vivo endothelial cell sprout formation assay that Smad1/5 deficiency impairs Notch signaling. This crosstalk of the BMP and Notch signaling pathways eventually determined the differentiation of endothelial cells in becoming either a tip or stalk cell [15] . We have previously shown that in endothelial cells beside the canonical Smad pathway, BMPER and TWSG1 also activate the alternative ERK1/2 and AKT signaling pathways [22] . Recently, activation of the PI3K/AKT pathway was also shown to act upstream of the Notch signaling pathway [52, 53] . Therefore, it is tempting to speculate that possibly along this way, the BMP pathway might synergistically increase Notch signaling activity. Collectively, we found that the BMP modulators BMPER and TWSG1 contribute to increase Notch signaling pathway activity and that inhibition of BMP pathway members impairs Notch signaling in endothelial cells. ) protein or control medium before cells were lysed and subjected to western blot analysis (A-F). NICD was increased after BMPER or TWSG1 stimulation in (A) HCAECs, (B) HUVECs, and (C) HMECs. Along the same line, downstream Notch signaling effector HES was increased in (D) HCAECs, (E) HUVECs, and (F) HMECs. Tubulin served as loading control. Values are means AE SEM; n = 6 (HUVECs), n = 4(HCAECs), n = 3 (HMECs); *P < 0.05 versus control. Sixteen hours after stimulation, RNA was isolated and subjected to qRT-PCR (G-L). Relative mRNA expression levels of (G) HES1, (H) HEY1, (I) HEY2, (J) VEGFR1, (K) EFNB2, and (L) EPHB4. hRPII serves as internal control. Notch target genes are upregulated after stimulation with recombinant BMPER (G-L). As Notch signaling induces arterial identity, EFNB2 expression is also increased and conversely expression of venous marker EPHB4 shows a trend toward downregulation. Values are means AE SEM; n = 3; *P < 0.05 versus control.
A central role for the BMP pathway during vascular remodeling and maturation was demonstrated by silencing the Bmpr2 in adult mice [54] . In these mice, vascular integrity is disturbed and the endothelial guidance molecules EphrinB1, B2 and A1, which promote vessel maturation and arterial specifications were concomitantly downregulated with ID1 expression, suggesting a correlation between the BMP pathway, Ephrins and arteriovenous specification. Along the same line, the genetic deletion of the BMP antagonist matrix Gla protein (MGP) in mice enhanced Notch signaling and disrupted endothelial cell differentiation [44] . MGP-deficient mice displayed increased EfnB2 and decreased EphB4 expression. Vice versa, we now show that silencing of bmper and twsg1b in zebrafish embryos increased ephb4a expression, while after inhibition of BMP4 by DMH1 BMPER and TWSG1 were unable to activate ID1 expression in endothelial cells and Notch signaling pathway activity. Moreover, zebrafish embryos treated with DMH1 displayed the same phenotype as bmper/twsg1b-MO-injected embryos with increased ephb4a expression (Figs 2 and 6 ), indicating that the loss of bmper and twsg1b is due to reduced BMP pathway activation. Thus, our findings show that BMPER and TWSG1 are not per se BMP antagonists, but depending on the local context and concentration, also elicit pro-BMP function [14, 22, 32, 38] . As discussed, inhibition of BMP signaling results in decreased Notch signaling. Insufficient Notch signaling was shown to lead to poor vasculature remodeling and maturation with formation of AVMs along with increased venous marker expression and decreased arterial marker expression [39] . Taken together, our findings in conjunction with published studies underline that the BMP signaling pathway is essential during blood vessel formation to avoid arteriovenous malformations.
In conclusion, we found that the BMP modulators, BMPER and TWSG1, contribute to increase Notch signaling pathway activity besides BMP4. Vice versa, inhibition of BMP pathway members impairs Notch signaling. Furthermore, our data suggest that unbalancing the BMP signaling pathway by inhibition of bmper and twsg1b in zebrafish leads to a predominant venous marker expression phenotype at the expense of arterial marker specification. Again, this indicates a dysregulation of the Notch signaling pathway that is well known to be centrally involved in arteriovenous specification.
Materials and methods

Cell culture and reagents
All experiments were performed according to the principles outlined in the Declaration of Helsinki for the use of human tissue. Human umbilical cords were obtained from the University Medical Centre Freiburg according to the guidelines of the local Medical Ethics Committee and after informed consent. HUVECs were freshly isolated from HUV of newborns by collagenase digestion [55] and were cultured in enhanced endothelial cell growth medium (PELOBiotech GmbH, Martinsried, Germany). At passage two, cells are analyzed for expression of endothelial markers such as PECAM-1 and VE-cadherin. For experiments, at least two batches were pooled and experiments were performed with at least three different pools of cells. HCAECs and human lung microvascular ECs (HMECs) were purchased and cultured in microvascular enhanced endothelial cell growth medium from PELOBiotech GmbH. Endothelial cells used in the experiments were between passages 4-6 and cultured without antibiotics. Endothelial cell basal media (EBM), PBS, and FBS were purchased from Lonza GmbH (Cologne, Germany). Recombinant human BMPER, human BMP4, human TWSG1 protein, and DMH1 were reconstituted according to the manufacturer's protocol (Bio-Techne GmbH/R&D Systems/Tocris, Wiesbaden, Germany). For cell stimulation/inhibitor experiments, subconfluent endothelial cells were washed twice with PBS, before they were incubated with EBM + 1% FBS alone, including recombinant proteins and/or inhibitor for 16 h.
RNA interference
Silencing of BMPER or TWSG1 by siRNA transfection in endothelial cells was performed as recently described [22] .
Western blot analysis
Cells were washed twice with ice-cold PBS and lysed on ice in RIPA buffer in the presence of protease inhibitor cocktail. To remove insoluble material, cells were centrifuged at 10 000 g for 10 min at 4°C and supernatants were collected. Total cellular protein was quantified using Bradford protein assay (Bio-Rad, Munich, Germany) and equal amounts of protein were loaded and separated by a 12% SDS/PAGE. Afterwards, proteins were transferred to nitrocellulose by electroblotting. ), a combination of both proteins or control medium was added for 16 h. Afterwards, cells were lysed and subjected to western blot analysis for NICD (A), HES1 (B), or ID1 (C). Values are means AE SEM; n = 5; *P < 0.05 versus control. RNA was isolated and qRT-PCR (D-G) was performed. Tubulin served as loading control. For mRNA expression analysis qRT-PCR for HEY1 (D), HEY2 (E), HES1 (F), and ID1 (G) was performed. Human RNA polymerase II serves as internal control. Values are means AE SEM; n = 3; *P < 0.05 versus control.
Western blots were blocked in 3% non-fat dried milk in TBST for 30 min and incubated overnight at 4°C with primary antibodies against NICD/NOTCH1 (#D1E11, Cell Signaling, Danvers, USA), HES (#ABIN2280956, antibodies-online GmbH, Aachen, Germany), BMPER (#MAB1956, R&D Systems/Bio-Techne GmbH), ID1 (#sc-734, Santa Cruz Biotechnology, Heidelberg, Germany), and tubulin (BD Bioscience, Heidelberg, Germany). Secondary antibodies used were conjugates with horseradish peroxidase (HRP): polyclonal antimouse-HRP (R&D Systems/Bio-Techne GmbH), anti-rabbit-HRP (Thermo Fisher Scientific, Darmstadt, Germany), antirat-HRP (Dako Deutschland GmbH, Hamburg, Germany). Visualization was performed by ECL (GE Healthcare, Buckinghamshire, UK) and a chemiluminescence detection system (ChemiDoc XRS; Bio-Rad). For quantification of protein band intensities, Image Lab (Bio-Rad) was used and expression normalized to tubulin loading control. Only western blots with protein bands that did not show signals of saturation were used for quantification.
RNA extraction and reverse transcription
DNA-free total RNA was extracted from HUVECs or zebrafish embryos using the Aurum RNA Mini Kit (Bio-Rad). Reverse transcriptions were performed with iScript cDNAKit applying 1 lg RNA following the manufacturer's protocol (Bio-Rad).
Quantitative real-time PCR
Quantitative RT-PCR analysis was performed using IQ SybrGreen 2xSupermix and the iCycler real-time PCR detection system (Bio-Rad). Primers were purchased from Eurofins MWG Operon, Ebersberg, Germany. The following primer sequences were used: hBMPER_fwd: In all, 50 cycles of thermocycling were performed with a denaturation step at 94°C for 5 s, an annealing step at 61°C for 30 s and extension step at 72°C for 30 s. Fluorescence was measured following each extension step. A final elongation step at 72°C for 5 min was performed before a melting curve was acquired and used to determine the PCR product specificity. Quantification was performed using MYIQ lightcycler software (Bio-Rad). The housekeeping gene hRP II was used for internal normalization for human cells and zebrafish elongation factor 1 alpha (efl1a) for zebrafish embryos. Relative quantification of target expression was calculated using the ΔΔCT method [56, 57] .
Fish strains, morpholino injections, and DMH1 treatment
Zebrafish procedures were approved by the Government Veterinary Office (Regierungspr€ asidium) and were performed according to the guidelines from Directive 2010/63/ EU of the European Parliament. Zebrafish embryos of the wild-type Tg(fli1:EGFP) line [58] were raised and staged as previously described [59, 60] . In this zebrafish line, the whole vasculature is green fluorescent because of the endothelialspecific activation of the ETS transcription factor Fli promoter sequences. Whole-mount in situ hybridization and GFP antibody staining
For synthesis of digoxigenin-labeled RNA probes, DIG RNA Labeling Kit (Roche, Mannheim, Germany) was used according to the manufacturer's instructions. Plasmids containing efnb2a and ephnb4a complete mRNA sequence were a gift from the Schulte-Merker lab and the Driever lab, respectively. Following the protocol from Thisse et al. [63] to generate the ephnb4a probe, a PCR with the pSPORT1 vector was performed and antisense probe was synthesized using T3 RNA polymerase (https://zfin.org/ ZDB-EST-030429-38). Antisense Efnb2a probes were generated by linearization of pGem-T-Easy vector containing full-length efnb2a cDNA with Sal1 followed by T7 RNA polymerase reaction. Subsequently, probes were fragmented using carbonate buffer (80 mM sodium carbonate, 120 mM sodium bicarbonate, pH 10.2) and incubated for 30 min at 42°C. Whole-mount in situ hybridization was performed using standard protocol from Thisse et al. [64] either with NBT/BCIP or with Fast Red substrate (both from Sigma Aldrich).
To assess expression of the marker gene ephrin in endothelial cells, Tg(fli1:EGFP) embryos were immunostained against GFP after completion of the in situ hybridization protocol. All incubation steps were performed on a shaking table. Embryos were washed three times in PBS with Triton X-100 (PBT) buffer, blocked in PBS/1% BSA/1% DMSO/0.5% Triton X-100 (PBDT) with 2% normal goat serum for 30 min, and incubated with monoclonal mouse anti-GFP (1 : 500; JL8, Takara Bio Europe/Clontech, Saint-Germain-en-Laye, France) at 4°C, overnight. Embryos were washed six times with PBDT for 2 h, before goat anti-mouse alexa-488 antibody (1 : 500; Molecular ProbesÒ; Thermo Fisher Scientific) was incubated overnight at 4°C. Afterwards, embryos were washed again for 2 h in PBDT and imaged with an inverted ZEISS spinning disk microscope at the Life Imaging Center, ZBSA, Freiburg, Germany.
Statistical analysis and quantification
Statistical analysis was performed using GRAPHPAD 5.0, La Jolla, CA, USA. Data are presented as mean AE SEM and comparisons of two groups were calculated by Student's ttest (two-sided, unpaired). All experiments were repeated at least three times in triplicates unless otherwise indicated. Results were considered statistically significant for P < 0.05.
